Skip to main content
OpenTrials
Completed

NCT Number: NCT06066151

The Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome

The goal of this single arm, open-label study is to learn about the efficacy of Minayo Iron-rich Yeast Drink with SOD on females who are aged 18-35 and suffer nutritional Anemia, skin condition and Qi-blood deficiency syndrome. The main question it aims to answer is:

- whether the serum ferritin level in blood is improved after the intervention

14 qualified participants will be enrolled to drink the product "Minayo Iron-rich Yeast Drink with SOD" for four weeks, once a day. Four site visits will be made for each participant so that all relevant clinical data will be captured and recorded for data analysis and reporting.

Researchers will compare the final blood test result (hemoglobin concentration level, Glutathione (GSH), Superoxide Dismutase (SOD)) against the baseline to conclude whether the product will be effective in improving Anemia and skin conditions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Shanghai Raison CMA Lab

Shanghai, Shanghai Municipality, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female, aged 18 to 35;
  • Hemoglobin concentration level below 110g/L based on WHO diagnostic criteria for anemia;
  • Agree not to take any drugs, supplements, or other dairy products during the trial;
  • Agree not to take any other medications or supplements containing iron during the trial;
  • Willing to refrain from participating in other interventional clinical studies during the trial period;
  • Be able to fully understand the purpose, benefits and potential risks including side effects of the research;
  • Willing to obey all test requirements and procedures;
  • Informed consent signed.

Exclusion criteria

  • Anemia caused by organic diseases;
  • Subject who is in the treatment of gastrointestinal symptoms;
  • Lactose intolerance;
  • Subject who is currently presence of other organic diseases affecting intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.;
  • Controlling diet, exercising, or taking medications to control weight or affect appetite in the last 3 months;
  • Subject who has any of the following medical history or clinical findings that may affect the evaluation of the trial effect: significant gastrointestinal disorders, liver, kidney, endocrine, hematological, respiratory and cardiovascular diseases;
  • Abuse alcohol or other drugs, supplement or OTC drugs currently or n the past may cause bowel dysfunction or can affect test result evaluation;
  • Frequently use of medications that may affect gastrointestinal function or the immune system according to investigator's judgment;
  • Take laxatives or other substances that promote digestion 2 weeks before the trail start;
  • Subject who used drugs or supplements of iron agent 10 days before the beginning of the trial;
  • Pregnant or lactating women or those planning to become pregnant during the trial;
  • PI deems that subjects could not fully cooperate with trial arrangements.

Treatment and study plan

Minayo Yeast Drink Product

Dietary Supplement

Participants need to drink one piece of the products each day, for 4 consecutive weeks.

Primary outcomes

  1. Change of Serum Ferritin Level

    Time frame: baseline day, end of week 4

    The change of serum ferritin level in blood, ng/mL (12~135ng/mL for healthy female, 27~375ng/mL for healthy male)

Secondary outcomes

  1. Hemoglobin Concentration Level

    Time frame: baseline day, end of week 4

    The change of hemoglobin concentration level in blood, g/L (115-150g/L)

  2. Superoxide Dismutase (SOD) Concentration Level

    Time frame: baseline day, end of week 4

    The change of Superoxide dismutase (SOD) concentration in blood, U/ml (1000~2000U/ml)

  3. Glutathione (GSH) Concentration Level

    Time frame: baseline day, end of week 4

    The change of Glutathione (GSH) concentration level in blood, mg/L (280~380mg/L)

  4. Skincare Measurement - Lines/Wrinkles

    Time frame: baseline day, end of week 4

    The changes of the lines/wrinkles on the face by Miravex Antera 3D imaging system

Sponsors and collaborators

Lead sponsor

Hangzhou Agile Groups Network Technology Co., Ltd.

Industry

Registry information

Official study title

A Single Arm, Open-label Study of the Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Oct 4, 2023
Registry last updated
Sep 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.